High-Dose Benzodiazepines Positively Modulate GABA Receptors Via a Flumazenil-Insensitive Mechanism

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Jan 11

PMID 35008465

Authors

Na Wang

Jingjing Lian

Yanqing Cao

Alai Muheyati

Shanshan Yuan

Yujie Ma

Shuzhuo Zhang

Gang Yu

Ruibin Su

Affiliations

Soon will be listed here.

Abstract

Benzodiazepines (BZDs) produce versatile pharmacological actions through positive modulation of GABA receptors (GABARs). A previous study has demonstrated that high concentrations of diazepam potentiate GABA currents on the αβγ and αβ GABARs in a flumazenil-insensitive manner. In this study, the high-concentration effects of BZDs and their sensitivity to flumazenil were determined on synaptic (αβγ, αβγ, αβγ) and extra-synaptic (αβδ) GABARs using the voltage-clamp electrophysiology technique. The in vivo evaluation of flumazenil-insensitive BZD effects was conducted in mice via the loss of righting reflex (LORR) test. Diazepam induced biphasic potentiation on the αβγ, αβγ and αβγ GABARs, but did not affect the αβδ receptor. In contrast to the nanomolar component of potentiation, the second potentiation elicited by micromolar diazepam was insensitive to flumazenil. Midazolam, clonazepam, and lorazepam at 200 µM exhibited similar flumazenil-insensitive effects on the αβγ, αβγ and αβγ receptors, whereas the potentiation induced by 200 µM zolpidem or triazolam was abolished by flumazenil. Both the GABAR antagonist pentylenetetrazol and Fa173, a proposed transmembrane site antagonist, abolished the potentiation induced by 200 µM diazepam. Consistent with the in vitro results, flumazenil antagonized the zolpidem-induced LORR, but not that induced by diazepam or midazolam. Pentylenetetrazol and Fa173 antagonized the diazepam-induced LORR. These findings support the existence of non-classical BZD binding sites on certain GABAR subtypes and indicate that the flumazenil-insensitive effects depend on the chemical structures of BZD ligands.

References

Gunja N . The clinical and forensic toxicology of Z-drugs. J Med Toxicol. 2013; 9(2):155-62. PMC: 3657020. DOI: 10.1007/s13181-013-0292-0. View

Celik T, Deniz G, Uzbay I, Palaoglu O, Ayhan I . The effects of flumazenil on two way active avoidance and locomotor activity in diazepam-treated rats. Eur Neuropsychopharmacol. 1999; 9(1-2):45-50. DOI: 10.1016/s0924-977x(97)00101-6. View

Auta J, Costa E, Davis J, Guidotti A . Imidazenil: an antagonist of the sedative but not the anticonvulsant action of diazepam. Neuropharmacology. 2005; 49(3):425-9. DOI: 10.1016/j.neuropharm.2005.04.005. View

McGrath M, Hoyt H, Pence A, Jayakar S, Zhou X, Forman S . Competitive Antagonism of Etomidate Action by Diazepam: In Vitro GABAA Receptor and In Vivo Zebrafish Studies. Anesthesiology. 2020; 133(3):583-594. PMC: 7944240. DOI: 10.1097/ALN.0000000000003403. View

Lian J, Cao Y, Li Y, Yu G, Su R . Flumazenil-Insensitive Benzodiazepine Effects in Recombinant αβ and Neuronal GABA Receptors. Brain Sci. 2020; 10(3). PMC: 7139822. DOI: 10.3390/brainsci10030150. View

Sigel E, Ernst M . The Benzodiazepine Binding Sites of GABA Receptors. Trends Pharmacol Sci. 2018; 39(7):659-671. DOI: 10.1016/j.tips.2018.03.006. View

Zhuo R, Peng P, Zheng J, Zhang Y, Wen L, Wei X . The glycine hinge of transmembrane segment 2 modulates the subcellular localization and gating properties in TREK channels. Biochem Biophys Res Commun. 2017; 490(3):1125-1131. DOI: 10.1016/j.bbrc.2017.06.200. View

Bonetti E, Pieri L, Cumin R, SCHAFFNER R, Pieri M, Gamzu E . Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology (Berl). 1982; 78(1):8-18. DOI: 10.1007/BF00470579. View

Middendorp S, Maldifassi M, Baur R, Sigel E . Positive modulation of synaptic and extrasynaptic GABAA receptors by an antagonist of the high affinity benzodiazepine binding site. Neuropharmacology. 2015; 95:459-67. DOI: 10.1016/j.neuropharm.2015.04.027. View

10.

Cao Y, Yan H, Yu G, Su R . Flumazenil-insensitive benzodiazepine binding sites in GABA receptors contribute to benzodiazepine-induced immobility in zebrafish larvae. Life Sci. 2019; 239:117033. DOI: 10.1016/j.lfs.2019.117033. View

11.

Farrant M, Nusser Z . Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci. 2005; 6(3):215-29. DOI: 10.1038/nrn1625. View

12.

Wongsamitkul N, Maldifassi M, Simeone X, Baur R, Ernst M, Sigel E . α subunits in GABA receptors are dispensable for GABA and diazepam action. Sci Rep. 2017; 7(1):15498. PMC: 5686171. DOI: 10.1038/s41598-017-15628-7. View

13.

Maldifassi M, Baur R, Pierce D, Nourmahnad A, Forman S, Sigel E . Novel positive allosteric modulators of GABAA receptors with anesthetic activity. Sci Rep. 2016; 6:25943. PMC: 4873749. DOI: 10.1038/srep25943. View

14.

Fernandez S, Karim N, Mewett K, Chebib M, Johnston G, Hanrahan J . Flavan-3-ol esters: new agents for exploring modulatory sites on GABA(A) receptors. Br J Pharmacol. 2011; 165(4):965-77. PMC: 3312492. DOI: 10.1111/j.1476-5381.2011.01615.x. View

15.

Masiulis S, Desai R, Uchanski T, Martin I, Laverty D, Karia D . GABA receptor signalling mechanisms revealed by structural pharmacology. Nature. 2019; 565(7740):454-459. PMC: 6370056. DOI: 10.1038/s41586-018-0832-5. View

16.

Sieghart W . Allosteric modulation of GABAA receptors via multiple drug-binding sites. Adv Pharmacol. 2015; 72:53-96. DOI: 10.1016/bs.apha.2014.10.002. View

17.

Rudolph U, Knoflach F . Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov. 2011; 10(9):685-97. PMC: 3375401. DOI: 10.1038/nrd3502. View

18.

Baird E, Hailey D . Delayed recovery from a sedative: correlation of the plasma levels of diazepam with clinical effects after oral and intravenous administration. Br J Anaesth. 1972; 44(8):803-8. DOI: 10.1093/bja/44.8.803. View

19.

Che Has A, Absalom N, van Nieuwenhuijzen P, Clarkson A, Ahring P, Chebib M . Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface. Sci Rep. 2016; 6:28674. PMC: 4921915. DOI: 10.1038/srep28674. View

20.

Chua H, Chebib M . GABA Receptors and the Diversity in their Structure and Pharmacology. Adv Pharmacol. 2017; 79:1-34. DOI: 10.1016/bs.apha.2017.03.003. View